1. Home
  2. MNKD vs PD Comparison

MNKD vs PD Comparison

Compare MNKD & PD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$3.38

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo PagerDuty Inc.

PD

PagerDuty Inc.

HOLD

Current Price

$14.83

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNKD
PD
Founded
1991
2009
Country
United States
United States
Employees
N/A
1155
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2004
2019

Fundamental Metrics

Financial Performance
Metric
MNKD
PD
Price
$3.38
$14.83
Analyst Decision
Buy
Buy
Analyst Count
8
9
Target Price
$8.69
$12.63
AVG Volume (30 Days)
3.4M
1.5M
Earning Date
05-06-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
416.95
EPS
N/A
0.19
Revenue
$348,966,000.00
$492,546,000.00
Revenue This Year
$35.81
$3.58
Revenue Next Year
$11.89
$2.88
P/E Ratio
N/A
$76.21
Revenue Growth
22.23
5.36
52 Week Low
$2.23
$5.70
52 Week High
$6.51
$16.91

Technical Indicators

Market Signals
Indicator
MNKD
PD
Relative Strength Index (RSI) 33.96 64.84
Support Level $3.30 $12.78
Resistance Level $4.29 $14.67
Average True Range (ATR) 0.17 0.48
MACD -0.04 -0.05
Stochastic Oscillator 19.91 82.89

Price Performance

Historical Comparison
MNKD
PD

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the company derives a majority of its revenue from the United States and the rest from International markets.

Share on Social Networks: